CBT-006
/ Cloudbreak Therap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 24, 2024
Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction
(clinicaltrials.gov)
- P2 | N=92 | Completed | Sponsor: Cloudbreak Therapeutics, LLC | Trial completion date: May 2022 ➔ Aug 2023 | Trial primary completion date: May 2022 ➔ Aug 2023
Trial completion date • Trial primary completion date
June 07, 2022
Safety, Efficacy and Pharmacokinetics of CBT-006 in Patients With Meibomian Gland Dysfunction
(clinicaltrials.gov)
- P2 | N=90 | Completed | Sponsor: Cloudbreak Therapeutics, LLC | Recruiting ➔ Completed | Trial completion date: Sep 2022 ➔ May 2022
Trial completion • Trial completion date
1 to 2
Of
2
Go to page
1